T. Rowe Price Associates
SNV

T. Rowe Price Associates’s Synovus SNV Stock Holding History

T. Rowe Price Associates’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-329,722
Closed -$16.5M – 3185
2025
Q4 		$16.5M Buy
329,722
+164,953
+100% +$7.93M ﹤0.01% 1105
2025
Q3 		$8.09M Sell
164,769
-245,418
-60% -$12.6M ﹤0.01% 1283
2025
Q2 		$21.2M Buy
410,187
+2,716
+0.7% +$125K ﹤0.01% 945
2025
Q1 		$19M Buy
407,471
+18,735
+5% +$967K ﹤0.01% 968
2024
Q4 		$19.9M Buy
388,736
+115,465
+42% +$5.98M ﹤0.01% 999
2024
Q3 		$12.2M Buy
273,271
+2,714
+1% +$119K ﹤0.01% 1105
2024
Q2 		$10.9M Buy
270,557
+39,701
+17% +$1.5M ﹤0.01% 1098
2024
Q1 		$9.25M Buy
230,856
+103,891
+82% +$3.91M ﹤0.01% 1126
2023
Q4 		$4.78M Buy
126,965
+3,780
+3% +$116K ﹤0.01% 1219
2023
Q3 		$3.43M Buy
123,185
+3,003
+2% +$93.9K ﹤0.01% 1279
2023
Q2 		$3.64M Buy
120,182
+3,161
+3% +$92.4K ﹤0.01% 1279
2023
Q1 		$3.61M Buy
117,021
+1,289
+1% +$49.1K ﹤0.01% 1261
2022
Q4 		$4.35M Buy
115,732
+3,178
+3% +$126K ﹤0.01% 1223
2022
Q3 		$4.22M Buy
112,554
+15,003
+15% +$595K ﹤0.01% 1238
2022
Q2 		$3.52M Buy
97,551
+23,475
+32% +$971K ﹤0.01% 1472
2022
Q1 		$3.63M Buy
74,076
+19,840
+37% +$1M ﹤0.01% 1525
2021
Q4 		$2.6M Sell
54,236
-2,452
-4% -$116K ﹤0.01% 1621
2021
Q3 		$2.49M Buy
56,688
+1,800
+3% +$76.1K ﹤0.01% 1645
2021
Q2 		$2.41M Buy
54,888
+1,428
+3% +$67.1K ﹤0.01% 1675
2021
Q1 		$2.45M Buy
53,460
+1,566
+3% +$65.6K ﹤0.01% 1644
2020
Q4 		$1.68M Sell
51,894
-12,744
-20% -$369K ﹤0.01% 1700
2020
Q3 		$1.37M Sell
64,638
-165
-0.3% -$3.44K ﹤0.01% 1671
2020
Q2 		$1.33M Buy
64,803
+6,232
+11% +$121K ﹤0.01% 1669
2020
Q1 		$1.03M Buy
58,571
+156
+0.3% +$4.81K ﹤0.01% 1687
2019
Q4 		$2.29M Sell
58,415
-4,032
-6% -$148K ﹤0.01% 1564
2019
Q3 		$2.23M Buy
62,447
+485
+0.8% +$17.4K ﹤0.01% 1551
2019
Q2 		$2.17M Sell
61,962
-91
-0.1% -$3.16K ﹤0.01% 1577
2019
Q1 		$2.13M Buy
62,053
+12,196
+24% +$448K ﹤0.01% 1576
2018
Q4 		$1.59M Buy
49,857
+581
+1% +$21.9K ﹤0.01% 1627
2018
Q3 		$2.26M Sell
49,276
-722,733
-94% -$36.4M ﹤0.01% 1590
2018
Q2 		$40.8M Sell
772,009
-136,526
-15% -$7.26M 0.01% 964
2018
Q1 		$45.4M Sell
908,535
-19,396
-2% -$977K 0.01% 913
2017
Q4 		$44.5M Sell
927,931
-40,689
-4% -$1.93M 0.01% 909
2017
Q3 		$44.6M Sell
968,620
-1,780,277
-65% -$77.2M 0.01% 891
2017
Q2 		$122M Buy
2,748,897
+8,499
+0.3% +$357K 0.02% 543
2017
Q1 		$112M Sell
2,740,398
-51,635
-2% -$2.15M 0.02% 566
2016
Q4 		$115M Sell
2,792,033
-1,541
-0.1% -$56.7K 0.02% 560
2016
Q3 		$90.9M Buy
2,793,574
+910,010
+48% +$28.6M 0.02% 605
2016
Q2 		$54.6M Sell
1,883,564
-9,968
-0.5% -$303K 0.01% 747
2016
Q1 		$54.7M Sell
1,893,532
-14,740
-0.8% -$422K 0.01% 739
2015
Q4 		$61.8M Buy
1,908,272
+22,543
+1% +$719K 0.01% 694
2015
Q3 		$55.8M Buy
1,885,729
+13,940
+0.7% +$427K 0.01% 738
2015
Q2 		$57.7M Buy
1,871,789
+2,406
+0.1% +$69.6K 0.01% 784
2015
Q1 		$52.4M Buy
1,869,383
+14,956
+0.8% +$406K 0.01% 826
2014
Q4 		$50.2M Buy
1,854,427
+4,162
+0.2% +$105K 0.01% 838
2014
Q3 		$43.7M Sell
1,850,265
-29,100
-2% -$698K 0.01% 880
2014
Q2 		$45.8M Sell
1,879,365
-15,715
-0.8% -$366K 0.01% 895
2014
Q1 		$45M Sell
1,895,080
-10,368
-0.5% -$252K 0.01% 894
2013
Q4 		$48M Sell
1,905,448
-47,839
-2% -$1.13M 0.01% 851
2013
Q3 		$45.1M Sell
1,953,287
-25,931
-1% -$591K 0.01% 849
2013
Q2 		$40.5M Buy
+1,979,218
New +$37.5M 0.01% 850

Other funds holding SNV

WBWA
William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

T. Rowe Price Associates's SNV Position: Q1 2026 in Review

T. Rowe Price Associates sold out of Synovus (SNV) in Q1 2026, closing a stake of 329,722 shares — an estimated $16.5M sold.

T. Rowe Price Associates first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $122M in Q2 2017. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • T. Rowe Price Associates reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Associates sold 329,722 Synovus shares in Q1 2026, an estimated $16.5M.
  • T. Rowe Price Associates first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • T. Rowe Price Associates's Synovus position peaked at $122M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.